Lead party: Belgian Investment Company for Developing Countries (BIO) (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Centre médical de la Communauté (private company) · Sector: Healthcare, Specialty Healthcare Providers, Primary Care Providers · Countries of operation: Democratic Republic of the Congo (DRC)
Transaction type: Debt Financing · Asset class: Private Credit · Strategy: Direct Lending · Instrument: Debt · Deal amount: US$3.1m
Lead investor/buyer: Belgian Investment Company for Developing Countries (BIO) · Investors/buyers: Belgian Investment Company for Developing Countries (BIO)
Legal advisers: not identified in the source record.
Source: announced 9 May 2016. Original announcement: bio-invest.be.


